Enanta Pharmaceuticals, Inc. Announces The Appointment Of Timothy D. Ocain, Ph.D. As Senior Vice President, New Product Strategy And Development

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) today announced the appointment of Timothy D. Ocain, Ph.D. as Senior Vice President, New Product Strategy and Development. Dr. Ocain has over 25 years’ experience working in the pharmaceutical and biotechnology environment with experience in medicinal chemistry, pharmacology, biochemistry, program management and preclinical and early development across multiple therapeutic areas. He is co-author on over 30 publications and co-inventor on 17 patents.

Help employers find you! Check out all the jobs and post your resume.